Suppr超能文献

两种一氧化氮合酶抑制剂对实验性结肠炎的不同作用

Differing effects of two nitric oxide synthase inhibitors on experimental colitis.

作者信息

Yamaguchi T, Yoshida N, Ichiishi E, Sugimoto N, Naito Y, Yoshikawa T

机构信息

Department of Gastroenterology, Takeda Hospital, Kyoto, Japan.

出版信息

Hepatogastroenterology. 2001 Jan-Feb;48(37):118-22.

Abstract

BACKGROUND/AIMS: The aim of this study was to investigate the effects of two inhibitors of nitric oxide synthase on a rat model of colitis.

METHODOLOGY

Colitis was induced by administration of an enema containing trinitrobenzene sulfonic acid. This colitis was treated everyday for one week with NG-nitro-L-arginine (10 mg/kg, i.v.), which is a non-selective inhibitor of both constitutive nitric oxide synthase and inducible nitric oxide synthase, or aminoguanidine (10 mg/kg, i.v.) which is an inhibitor of inducible nitric oxide synthase. Exposure to the trinitrobenzene sulfonic acid enema inhibited the increase in body weight of rats, and markedly increased the colonic damage scores, wet weight, thiobarbituric acid-reactive substances and myeloperoxidase activity.

RESULTS

The inhibition of weight increase caused by trinitrobenzene sulfonic acid was significantly reduced by aminoguanidine treatment, whereas weight loss tended to be aggravated by NG-nitro-L-arginine treatment. The increases in the colonic damage scores, wet weight, thiobarbituric acid-reactive substances and myeloperoxidase activity in trinitrobenzene sulfonic acid-colitis were significantly inhibited by aminoguanidine treatment, although they tended to be aggravated by NG-nitro-L-arginine treatment.

CONCLUSIONS

These results suggest that an inhibitor of inducible nitric oxide synthase, but not of constitutive nitric oxide synthase, was effective in treating experimental colitis in rats.

摘要

背景/目的:本研究旨在探究两种一氧化氮合酶抑制剂对大鼠结肠炎模型的影响。

方法

通过给予含三硝基苯磺酸的灌肠剂诱导结肠炎。用非选择性抑制组成型一氧化氮合酶和诱导型一氧化氮合酶的NG-硝基-L-精氨酸(10毫克/千克,静脉注射)或作为诱导型一氧化氮合酶抑制剂的氨基胍(10毫克/千克,静脉注射)对该结肠炎进行为期一周的每日治疗。暴露于三硝基苯磺酸灌肠剂会抑制大鼠体重增加,并显著提高结肠损伤评分、湿重、硫代巴比妥酸反应性物质和髓过氧化物酶活性。

结果

氨基胍治疗可显著减轻三硝基苯磺酸所致的体重增加抑制,而NG-硝基-L-精氨酸治疗则往往会加重体重减轻。氨基胍治疗可显著抑制三硝基苯磺酸诱导的结肠炎中结肠损伤评分、湿重、硫代巴比妥酸反应性物质和髓过氧化物酶活性的增加,尽管NG-硝基-L-精氨酸治疗往往会使其加重。

结论

这些结果表明,诱导型一氧化氮合酶抑制剂而非组成型一氧化氮合酶抑制剂对治疗大鼠实验性结肠炎有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验